Active Share (vs S&P 500): 100.0%
· vs QQQ: 100.0%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-14.0%
· vs SPY
-16.1%
· Prev Value $431.06M
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
+3.5%
· vs SPY
+1.4%
· Latest Value $280.09M
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, FINDELL CAPITAL MANAGEMENT LLC disclosed 13 equity positions with a combined reported value of $280.09M. The filing implies a focused portfolio: its ten largest positions account for 93.2% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q3 2026 were ESTA ($51.66M), DAVE ($46.62M), CELH ($27.35M). By sector, the heaviest allocations are Health Care 34.7%, Financials 33.4%. Versus the prior quarter, allocation shifted toward Financials (+8.6pp), Consumer Discretionary (+6.7pp) and away from Technology (-3.1pp), Health Care (-16.9pp).
Versus the prior quarter, FINDELL CAPITAL MANAGEMENT LLC opened 3 new positions, trimmed 5 and fully exited 2, a turnover rate of 66.7% of positions. The portfolio's overlap with the prior quarter was 67% of names.
The largest new positions opened in Q3 2026 were WRBY ($11.81M), QDEL ($4.74M), VRRM ($2.48M).
Of the 2 positions fully exited versus the prior quarter, the largest were FIG ($13.48M), RKT ($11.03M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest FINDELL CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Findell Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 13 US equity positions with a combined value of $280.09M. HoldingsHub carries 12 quarters of its filings (Q4 2023–Q3 2026).
Regulatory AUM (Form ADV): $375.78M as of 2026-07-22
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 2 private funds, of which 2 hedge funds
Website: fincap.us
Portfolio Structure
13 positions · $280.09M reported value (Q3 2026)
Top 10 holdings = 93.2% of reported value
Largest position: ESTA (ESTABLISHMENT LABS HLDGS INC) at 18.4%
Average position size: $21.55M
Sector Tilt
Health Care 34.7%
Financials 33.4%
Consumer Discretionary 22.1%
(classified holdings cover 100% of value)
Quarterly Activity
Q3 2026: 3 new, 4 added, 5 reduced, 2 exited
1 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure to Health Care (ESTA, ABVX, LQDA) and Consumer Discretionary (GEO), while adding to Financials (DAVE, ROOT, OPRT), Consumer Staples (CELH), and Consumer Discretionary (SGHC, TPB), suggesting a tilt toward economically sensitive sectors with potential growth.
2. Key moves:
- Added: CELH (+33.3% shares), SGHC (+4.8%), ROOT (+15.9%), TPB (+23.5%).
- Reduced: ESTA (-26.6%), GEO (-8.8%), ABVX (-8.1%), LQDA (-69.0%), OPRT (-2.3%).
- Hold: DAVE (no change).
3. Portfolio structure: Active management with a bias toward Financials and Consumer sectors; moderate risk appetite (significant position sizing and turnover).
4. Per-holding one-liner:
- ESTA: Medical devices (Establishment Labs) – unverified.
- DAVE: Neobank (Dave Inc).
- CELH: Energy drinks (Celsius Holdings).
- SGHC: E-sports (Super Group SGHC) – unverified.
- ROOT: Insurtech (Root Inc).
- OPRT: Fintech (Oportun Financial).
- GEO: Private prisons (GEO Group).
- ABVX: Biotech (Abivax SA) – unverified.
- TPB: Apparel (Turning Point Brands).
- LQDA: Medical devices (Liquidia Corporation) – unverified.
5. Style summary: Rotated out of healthcare and consumer discretionaries into financials and consumer staples, favoring high-growth, economically sensitive names.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 13:38
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2023-Q4 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
Why there is no forecast NAV
Not published because:
Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 100%R 100%F1 100%(modelled on 2026-Q2; 10/10 hit)
Low-confidence forecast
This fund replaces about 32% of its Top-10 each quarter and
backtests at F1 67% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
LQDA · VAL · NE · VET · CZR · EXEL · SLCA · EHTH · ESTA · OPRT
VAL · NE · EXEL · GTM · OPRT · DAVA · VET · CC · TDS · EHTH
2024-Q3
60%
60%
60%
VAL · NE · EXEL · OPRT · GTM · DAVA · CC · VET · TDS · EHTH
LQDA · APLD · GTM · DAVA · OPRT · NE · NMM · EXEL · CC · GRPN
2024-Q4
40%
40%
40%
LQDA · APLD · GTM · DAVA · OPRT · NE · NMM · EXEL · CC · GRPN
ESTA · LQDA · QQQ · GEO · DAVA · OPRT · EHTH · VAL · GRPN · VRNA
2025-Q1
80%
80%
80%
ESTA · LQDA · QQQ · GEO · DAVA · OPRT · VAL · EHTH · GRPN · VRNA
ESTA · LQDA · GEO · OPRT · VAL · ODP · DAVA · EHTH · GRPN · MLYS
2025-Q2
70%
70%
70%
ESTA · LQDA · GEO · OPRT · VAL · ODP · DAVA · EHTH · MLYS · GRPN
ESTA · ODP · OPRT · GEO · VAL · ROOT · AEVA · CC · DAVA · EHTH
2025-Q3
40%
40%
40%
ESTA · ODP · OPRT · GEO · VAL · ROOT · CC · AEVA · DAVA · EHTH
ESTA · LQDA · OPRT · ODP · GEO · MLYS · TPB · SGHC · DAVE · BTU
2025-Q4
60%
60%
60%
ESTA · LQDA · OPRT · ODP · GEO · TPB · SGHC · MLYS · DAVE · BTU
ESTA · ROOT · DAVE · TPB · OPRT · SGHC · GEO · CELH · EHTH · ABVX
2026-Q1
80%
80%
80%
ESTA · ROOT · DAVE · TPB · OPRT · SGHC · GEO · CELH · ABVX · EHTH
ESTA · DAVE · ROOT · SGHC · GEO · OPRT · ABVX · CVE · ACHC · TPB
2026-Q2
80%
80%
80%
ESTA · DAVE · ROOT · SGHC · GEO · ABVX · OPRT · CVE · ACHC · TPB
LQDA · ESTA · DAVE · SGHC · ROOT · ABVX · GEO · CELH · OPRT · TPB
2026-Q3 ★
100%
100%
100%
LQDA · ESTA · DAVE · SGHC · ROOT · ABVX · CELH · GEO · OPRT · TPB
ESTA · DAVE · CELH · SGHC · ROOT · OPRT · GEO · ABVX · TPB · LQDA
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-16.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.
Portfolio return+23.18%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+40.20%vs benchmark
Barra annualised vol70.0%Model estimate
Realised vol62.3%Annualised in window
Weighted beta1.43Raw exposure
Factor / specific risk43% / 57%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+23.18%
Disclosed long book
QQQ synthetic benchmark
-17.01%
Liquidity-weighted constituents
Model universe, equal weight
-1.70%
Opportunity-cost reference
Excess return
+40.20%
Portfolio − benchmark
Arithmetic return sum
+23.46%
Difference vs compounded is the cross term
Weighted raw beta
1.43
Weighted holding betas
Realised volatility (annualised)
62.27%
Daily returns in window
Barra model volatility (annualised)
70.01%
Factor + specific
Factor share of variance
43.3%
Barra factors
Specific share of variance
56.7%
Stock residuals
Reported value
$36.8M
13F long US equity
2. Return attribution
The +23.46% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-1.30%
-5.5%
Momentum & Growth
3
-1.93%
-8.2%
Volatility & Tail Risk
7
-5.32%
-22.7%
Industry
12
+0.44%
1.9%
Specific
1
+31.57%
134.5%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Specific
Specific
—
—
+31.57%
134.5%
Kurtosis
Style
+1.24
+7.51%
+9.30%
39.6%
Skewness
Style
-1.76
-4.39%
+7.72%
32.9%
Residual Volatility
Style
+1.22
+3.29%
+4.01%
17.1%
Size
Style
-1.66
-1.95%
+3.23%
13.8%
Non-linear Size
Style
+3.07
+1.01%
+3.10%
13.2%
Beta
Style
+0.58
+4.44%
+2.58%
11.0%
Max Drawdown
Style
-1.38
-1.76%
+2.44%
10.4%
Health Care
Industry
+0.33
+6.98%
+2.32%
9.9%
Short-term Reversal
Style
+1.41
+0.87%
+1.23%
5.2%
Liquidity
Style
-1.04
+0.36%
-0.37%
-1.6%
Turnover
Style
+0.18
-4.80%
-0.86%
-3.7%
Amihud Illiquidity
Style
+2.75
-0.45%
-1.23%
-5.2%
Momentum
Style
+0.39
-4.00%
-1.57%
-6.7%
Growth
Style
-0.91
+1.75%
-1.60%
-6.8%
Financials
Industry
+0.67
-2.80%
-1.87%
-8.0%
Leverage (Downside Vol)
Style
+2.87
-1.71%
-4.93%
-21.0%
Mid Cap
Style
+2.67
-1.94%
-5.17%
-22.0%
Historical Volatility
Style
+1.89
-14.00%
-26.43%
-112.7%
3. Risk attribution
Annualised volatility is 70.01%; factor risk explains 43.3% of variance and specific risk 56.7%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
56.7%
+39.68%
39.7%
Historical Volatility
Style
+1.89
14.2%
+9.93%
9.9%
Leverage (Downside Vol)
Style
+2.87
10.3%
+7.23%
7.2%
Financials
Industry
+0.67
6.5%
+4.54%
4.5%
Mid Cap
Style
+2.67
6.3%
+4.44%
4.4%
Non-linear Size
Style
+3.07
5.2%
+3.63%
3.6%
Max Drawdown
Style
-1.38
3.0%
+2.11%
2.1%
Size
Style
-1.66
2.5%
+1.73%
1.7%
Liquidity
Style
-1.04
1.6%
+1.14%
1.1%
Health Care
Industry
+0.33
1.3%
+0.94%
0.9%
Momentum
Style
+0.39
0.2%
+0.16%
0.2%
Short-term Reversal
Style
+1.41
-0.3%
-0.21%
-0.2%
Beta
Style
+0.58
-0.5%
-0.37%
-0.4%
Kurtosis
Style
+1.24
-2.3%
-1.64%
-1.6%
Skewness
Style
-1.76
-4.3%
-3.01%
-3.0%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-1.66
+2.10
-3.76
Non-linear Size
+3.07
+1.68
+1.39
Mid Cap
+2.67
+0.13
+2.54
Beta
+0.58
+1.29
-0.71
Momentum
+0.39
+0.72
-0.32
Short-term Reversal
+1.41
-0.64
+2.05
Residual Volatility
+1.22
-0.40
+1.62
Historical Volatility
+1.89
+0.86
+1.03
Liquidity
-1.04
+0.11
-1.15
Amihud Illiquidity
+2.75
+1.16
+1.60
Turnover
+0.18
+0.21
-0.03
Growth
-0.92
+0.58
-1.50
Leverage (Downside Vol)
+2.87
+0.14
+2.73
Skewness
-1.76
+0.24
-1.99
Kurtosis
+1.24
+0.21
+1.02
Max Drawdown
-1.38
-0.08
-1.30
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Health Care
33.2%
1.7%
+86.29%
+8.29%
+8.00%
+1.35%
+24.54%
+28.50%
Information Technology
0.0%
73.6%
+0.00%
-22.33%
+3.83%
+16.44%
-16.44%
+16.44%
Communication Services
0.0%
2.6%
+0.00%
-17.64%
+0.01%
+0.46%
-0.46%
+0.46%
Utilities
0.0%
0.8%
+0.00%
+11.13%
-0.22%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.26%
-0.27%
-0.13%
+0.13%
-0.13%
Consumer Discretionary
0.0%
8.8%
+0.00%
+3.76%
-1.84%
-0.33%
+0.33%
-0.33%
Industrials
0.0%
11.1%
+0.00%
+4.36%
-2.39%
-0.48%
+0.48%
-0.48%
Financials
66.8%
0.0%
-2.00%
+0.00%
+11.44%
-0.00%
-1.33%
-1.33%
Total
+18.45%
+17.19%
+7.37%
+43.01%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
ROOT
ROOT INC
Financials
66.81%
-1.99%
-1.33%
Add
LQDA
LIQUIDIA CORPORATION
Health Care
33.19%
+86.29%
+28.64%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
LQDA
Health Care
33.19%
+86.29%
+28.64%
2
ROOT
Financials
66.81%
-1.99%
-1.33%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +23.18%, versus -17.01% for the QQQ synthetic benchmark — an excess of +40.20%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +9.30%, Skewness +7.72%, Residual Volatility +4.01%; the largest drags came from Historical Volatility -26.43%, Mid Cap -5.17%, Leverage (Downside Vol) -4.93%. Specific (stock-level) return contributed +31.57%.
Risk attribution: Barra model volatility is 70.01% annualised; factor risk explains 43% of variance and specific risk 57%. The largest factor risk sources are Historical Volatility 14.2%, Leverage (Downside Vol) 10.3%, Financials 6.5%.
Style tilt: size -1.66, momentum +0.39, volatility +1.89, liquidity -1.04; the weighted raw beta is 1.43. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Financials (+66.8 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +18.45%, selection +17.19% and interaction +7.37%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did FINDELL CAPITAL MANAGEMENT LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, FINDELL CAPITAL MANAGEMENT LLC reported 13 equity positions worth $280.09M in aggregate; its largest disclosed positions were ESTA ($51.66M), DAVE ($46.62M), CELH ($27.35M).
How large is FINDELL CAPITAL MANAGEMENT LLC's portfolio?
FINDELL CAPITAL MANAGEMENT LLC reported $280.09M of long equity holdings across 13 positions as of 2026-Q3. Top-10 holdings account for 93.2% of reported value.
What is FINDELL CAPITAL MANAGEMENT LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/findell-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>